These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages. Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611 [TBL] [Abstract][Full Text] [Related]
43. [Animal experiments on the toxicity of cadmium stearates]. Schmidt P; Gohlke R Z Gesamte Hyg; 1971 Nov; 17(11):827-31. PubMed ID: 5169410 [No Abstract] [Full Text] [Related]
44. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]. Grosset J; Truffot C; Fermanian J; Lecoeur H Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288 [TBL] [Abstract][Full Text] [Related]
45. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis]. Mkrtchian SV; Ushkin VV Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224 [No Abstract] [Full Text] [Related]
46. [Effect of polyvinylpyrrolidone on toxic properties of streptomycin and monomycin]. Kochetkova VA Antibiotiki; 1970 Jan; 15(1):71-6. PubMed ID: 4909953 [No Abstract] [Full Text] [Related]
47. [Therapeutic effect of interleukin-12 on murine infection with Mycobacterium tuberculosis through modulating Th1 and Th2 cytokine balance]. Zhang T; Kawakami K; Tang Y Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):358-60. PubMed ID: 11778519 [TBL] [Abstract][Full Text] [Related]
48. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy]. Rist N Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388 [No Abstract] [Full Text] [Related]
49. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin]. Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844 [No Abstract] [Full Text] [Related]
50. [Histochemical changes in the internal organs during experiment treatment of tuberculosis with proteolytic enzymes]. Shlapak PT; Shvartsman LIa Probl Tuberk; 1972; 50(11):70-5. PubMed ID: 4567253 [No Abstract] [Full Text] [Related]
52. [Effect of Neguvon on free amino acids, some animal tissues and cell cultures]. Bădescu C; Hrisanidi S; Mihai MD; Samoilescu M Wiad Parazytol; 1972; 18(4):675-86. PubMed ID: 4660771 [No Abstract] [Full Text] [Related]
53. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)]. Hoffmeister F; Wuttke W; Kroneberg G Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764 [No Abstract] [Full Text] [Related]
54. [Effect of chemotherapeutic agents on the dynamics of Mycobacterium tuberculosis antigen titers in organ homogenates during treatment of and following recovery from experimental tuberculosis]. Romanova RIu Probl Tuberk; 1969; 47(3):74-8. PubMed ID: 5354638 [No Abstract] [Full Text] [Related]
55. [Morphological changes in the liver of guinea pigs with minor tubercular changes treated for a prolonged period with streptomycin, phthivazid and PASK]. Rudaĭtene AP Probl Tuberk; 1970; 48(4):78-82. PubMed ID: 5528471 [No Abstract] [Full Text] [Related]
56. Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis. Vladimirsky MA; Ladigina GA Biomed Pharmacother; 1982; 36(8-9):375-7. PubMed ID: 7182018 [TBL] [Abstract][Full Text] [Related]
57. [Prospects of the use of adaptogenic amino acids in the pathogenetic therapy of a number of pathologic states]. Pavlov VA; Sabadash EV Probl Tuberk; 2002; (11):26-8. PubMed ID: 12501793 [No Abstract] [Full Text] [Related]
58. [Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo]. Ota Y Kekkaku; 1971 Dec; 46(12):493-500. PubMed ID: 5004603 [No Abstract] [Full Text] [Related]
59. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria. Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885 [No Abstract] [Full Text] [Related]
60. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols]. Tomioka H; Saito H Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]